Latest Derivatives News

MTM Critical Metals has achieved a breakthrough in recovering high-grade antimony from U.S.-sourced electronic waste, surpassing traditional mine grades and supporting U.S. efforts to secure critical metal supplies amid global supply disruptions.

Bio-Gene Technology Limited has raised $338,500 through a Share Purchase Plan, contributing to a total capital raise of $2.45 million to advance its bio-insecticide products.

Soul Patts and Brickworks have announced a transformative merger to create Washington H. Soul Pattinson, a new $14 billion ASX-listed company that promises simplified ownership and enhanced shareholder value.

Chilwa Minerals Limited has reported strong assay results from its Mpyupyu Dune deposit in Malawi, reinforcing the potential for a significant upgrade to its mineral resource estimates. Improved assay turnaround times are accelerating progress across multiple deposits.

Augustus Minerals has reported striking visible gold and exceptional assay results from rock chip sampling at its expansive Music Well project in Western Australia, signaling promising exploration progress.

European Lithium Limited has clarified its mineral resource estimates and production targets for the Tanbreez Project following an ASX compliance query, reaffirming its basis for financial forecasts despite cautionary geological statements.

Avecho Biotechnology has received $1.66 million from the Australian Government’s R&D Tax Incentive, reinforcing its commitment to a pivotal Phase III trial for its CBD-based insomnia treatment and accelerating its commercial ambitions.

NoviqTech and Livium have partnered to digitise and tokenise the environmental benefits of battery recycling, aiming to enhance transparency and compliance in the critical minerals supply chain.

Web Travel Group Limited reported a robust 22% increase in Total Transaction Value for FY25, despite a 14% dip in EBITDA due to margin pressures and higher costs. The company is strategically investing in supply and technology to target $10 billion TTV by FY30.

Nufarm Limited confirms its half-year earnings align closely with analyst expectations despite a late-stage $16 million inventory valuation adjustment. The company maintains compliance with ASX disclosure rules amid market scrutiny.

Golden Horse Minerals reports outstanding initial metallurgical test results from its Hopes Hill gold project, with average gold recoveries nearing 97%, signaling strong processing potential.

Zelira Therapeutics has published full results from a Phase I study showing its cannabinoid-based therapy ZLT-L-007 significantly outperforms Lyrica® in managing diabetic neuropathy pain and related symptoms.